Molecular Imaging to Study Antimicrobial Pharmacokinetics In Vivo

Area of Science:

• Pharmacology
• Infectious Diseases
• Medical Imaging

Background:

• Antimicrobials are widely prescribed, but older antibiotics often lack optimized dosing, administration routes, and therapy durations.
• Significant knowledge gaps persist regarding the complex microenvironments within infected tissues, including bacterial loads, immune responses, and drug distribution gradients.

Purpose of the Study:

• To review the concepts, history, and recent advancements in utilizing positron-emission tomography (PET) imaging for optimizing antimicrobial therapy.
• To highlight how PET-based imaging can address knowledge gaps in antibiotic pharmacokinetics within heterogeneous infected tissues.

Main Methods:

• Review of existing literature on PET imaging applications in pharmacology and infectious diseases.
• Discussion of the principles of visualizing radiolabeled drugs in vivo using PET.
• Analysis of how PET provides real-time, holistic pharmacokinetic data.

Main Results:

• PET imaging allows for accurate, real-time visualization of drug distribution and concentration within infected tissues.
• This approach provides actionable data to understand drug gradients and tissue penetration.
• The technology enables a holistic view of pharmacokinetics, overcoming limitations of traditional methods.

Conclusions:

• Positron-emission tomography imaging is a powerful tool for determining pharmacokinetics and optimizing antibiotic use.
• This technique can bridge knowledge gaps concerning heterogeneous tissue microenvironments and drug efficacy.
• Advancements in PET imaging offer a promising future for personalized and effective antimicrobial strategies.